Differences Between Plasma and CSF GFAP Levels Across the Alzheimer Disease Continuum

This cross-sectional cohort study evaluates plasma glial fibrillary acidic protein levels throughout the entire Alzheimer disease continuum, from preclinical Alzheimer disease to Alzheimer disease dementia, compared with cerebrospinal fluid glial fibrillary acidic protein.
Source: JAMA Neurology - Category: Neurology Source Type: research